ES2071481T3 - Prevencion de adherencias sinoviales. - Google Patents

Prevencion de adherencias sinoviales.

Info

Publication number
ES2071481T3
ES2071481T3 ES92901765T ES92901765T ES2071481T3 ES 2071481 T3 ES2071481 T3 ES 2071481T3 ES 92901765 T ES92901765 T ES 92901765T ES 92901765 T ES92901765 T ES 92901765T ES 2071481 T3 ES2071481 T3 ES 2071481T3
Authority
ES
Spain
Prior art keywords
synovial
adherences
prevention
adhesions
intercalated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901765T
Other languages
English (en)
Inventor
Larry J Moore
Jill Adler-Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexstar Pharmaceuticals Inc
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Application granted granted Critical
Publication of ES2071481T3 publication Critical patent/ES2071481T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Revetment (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LAS ADHESIONES EN LAS CAPSULAS SINOVIALES SE EVITAN A TRAVES DE LA ADMINISTRACION DE AGENTES ANTIINFLAMATORIOS NO ESTEROIDEOS INTERCALADOS CON LIPOSOMAS.
ES92901765T 1990-12-03 1991-12-03 Prevencion de adherencias sinoviales. Expired - Lifetime ES2071481T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62162590A 1990-12-03 1990-12-03

Publications (1)

Publication Number Publication Date
ES2071481T3 true ES2071481T3 (es) 1995-06-16

Family

ID=24490933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901765T Expired - Lifetime ES2071481T3 (es) 1990-12-03 1991-12-03 Prevencion de adherencias sinoviales.

Country Status (11)

Country Link
US (1) US5411743A (es)
EP (1) EP0560900B1 (es)
JP (1) JPH06507882A (es)
AT (1) ATE118168T1 (es)
AU (1) AU664359B2 (es)
CA (1) CA2099588C (es)
DE (1) DE69107309T2 (es)
DK (1) DK0560900T3 (es)
ES (1) ES2071481T3 (es)
GR (1) GR3015663T3 (es)
WO (1) WO1992009268A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127884A1 (en) * 1994-12-12 2004-07-01 Omeros Corporation Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US6413961B1 (en) * 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
JP2004135177A (ja) 2002-10-11 2004-04-30 Sharp Corp 携帯電話機
ES2330295B1 (es) 2008-06-06 2010-09-23 Laboratorios Alcala Farma, Sl Formulacion topica de ibuprofeno.
JP6194248B2 (ja) 2010-10-28 2017-09-06 パシラ ファーマシューティカルズ インコーポレーテッド 非ステロイド性抗炎症薬の徐放性処方物
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
IN166447B (es) * 1985-11-27 1990-05-12 Ethicon Inc
EP0225162B1 (en) * 1985-11-27 1992-01-22 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug
EP0249561B1 (en) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
GB2217596A (en) * 1988-04-26 1989-11-01 American Cyanamid Co Anti-arthritic liposome composition
WO1991016920A1 (en) * 1990-05-07 1991-11-14 Vical, Inc. Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
DE69107309D1 (de) 1995-03-23
EP0560900B1 (en) 1995-02-08
CA2099588C (en) 2003-04-15
EP0560900A1 (en) 1993-09-22
US5411743A (en) 1995-05-02
DK0560900T3 (da) 1995-05-08
AU9127991A (en) 1992-06-25
JPH06507882A (ja) 1994-09-08
ATE118168T1 (de) 1995-02-15
CA2099588A1 (en) 1992-06-04
AU664359B2 (en) 1995-11-16
GR3015663T3 (en) 1995-07-31
WO1992009268A1 (en) 1992-06-11
DE69107309T2 (de) 1995-06-08

Similar Documents

Publication Publication Date Title
BR9201056A (pt) Agentes de encrespamento
NO942923L (no) Medikamenter
FI965154L (fi) Lääkkeen paksusuoleen kuljettava koostumus
FI932692L (fi) Hydroxamsyraderivat
ITMI913324A0 (it) Agenti farmaceutici
NO930677L (no) Farmasoeytiske forbindelser
FI923114A0 (fi) Turvalaitejärjestely
ES2071481T3 (es) Prevencion de adherencias sinoviales.
DE69305413D1 (de) Pulverisierungsvorrichtung
DK115588D0 (da) Valsemoelle
DE59305734D1 (de) Gehäuse für freistehende Automaten und dergleichen
FI943100L (fi) Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina
EP0458160A3 (en) Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
DK25592D0 (da) Slaamaskine for graesafgroeder
FI935065A0 (fi) Farmaceutiska foereningar
NO931008D0 (no) Farmasoeytiske forbindelser
DE69302723D1 (de) Mehrreihige Wechselrichteranordnung
NO933506D0 (no) Ioderte fuktemidler
FI953833A0 (fi) Murskain
FI951594A7 (fi) Uudet farmauttiset spiramysiiniseokset
AT399669B (de) Zerkleinerungsmaschine
ITFI920181A0 (it) Derivati penems; loro preparazione e composizioni farmacologiche che li contengono
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
DK143693D0 (da) Valsemoelle
IT226205Z2 (it) Frantoio rotante